Pfizer's oncology business reported strong growth in Q4 as the firm looks ahead to further expansion of its breast cancer and ...

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

Sep. 16, 2024 — Long-term data from a landmark international trial show about half of patients with metastatic melanoma treated with a combination of immune ... Experimental mRNA Cancer Vaccine ...

This study presents fundamental insights into overcoming resistance in hormone receptor-positive breast cancer by demonstrating that sustained CDK4/6 inhibitor treatment, either alone or in ...

Other drugs help the immune system to attack the cancer. They are called immunotherapies. This page is about targeted cancer drugs and immunotherapy for melanoma skin cancer that: can be removed with ...

A mom of four is struggling with stage four melanoma, which spread to her brain while she was pregnant — and she alleges it could have been avoided if her doctors had listened to her.

Kelly Heather, 38, first noticed a dark line on her fingernail, which turned out to be an aggressive melanoma that eventually required her finger to be amputated She says doctors refused to provide ...

“Also, we have these novel therapies in the early breast cancer space such as CDK4/6 inhibitors. Those therapies may change the way we think about chemotherapy and anthracyclines for these patients.

Researchers created an injectable hydrogel composed of cyclin-dependent kinase 4/6 inhibitor Abemaciclib (Abe)-loaded peptide-NLG919 prodrug nanofibers, namely Abe-NF(g). They demonstrated that ...

The stage of melanoma skin cancer tells you how thick it is and how far it has spread. Doctors use different systems to stage melanoma. These include the TNM system and number staging system. The ...

Elon Musk has addressed Donald Trump’s victory rally in Washington DC on the eve of the US President-elect’s inauguration.

Crizotinib is under clinical development by Pfizer and currently in Phase II for Uveal Melanoma. According to GlobalData, Phase II drugs for Uveal Melanoma have a 29% phase transition success rate ...